MC
BMY icon

Middleton & Co’s Bristol-Myers Squibb BMY Stock Holding History

Middleton & Co’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-3,316
Closed -$244K – 158
2016
Q2 		$244K Hold
3,316
– – 0.06% 144
2016
Q1 		$212K Hold
3,316
– – 0.05% 150
2015
Q4 		$228K Buy
+3,316
New +$219K 0.05% 149

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Middleton & Co's BMY Position: Q3 2016 in Review

Middleton & Co sold out of Bristol-Myers Squibb (BMY) in Q3 2016, closing a stake of 3,316 shares — an estimated $244K sold.

Middleton & Co first reported a position in BMY in Q4 2015 and held it in 3 quarters. The position peaked at $244K in Q2 2016. 1,522 funds tracked by Wall St. Rank hold BMY as of Q3 2016.

  • Middleton & Co reported no remaining Bristol-Myers Squibb position as of Q3 2016 after selling out during the quarter.
  • Middleton & Co sold 3,316 Bristol-Myers Squibb shares in Q3 2016, an estimated $244K.
  • Middleton & Co first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 3 quarters.
  • Middleton & Co's Bristol-Myers Squibb position peaked at $244K in Q2 2016.
  • 1,522 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2016.

Based on Middleton & Co's 13F filing for Q3 2016, filed 27 Oct 2016.